Abiopharma

Lipocines PPD Phase 3 Study (LPCN 1154) Hits 80% Enrollment Milestone

Zimmer Biomet Holdings, Inc. Notification

Integer Holdings Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – ITGR

Repligen Introduces Next-Generation Chromatography Resins to Advance New Modality Workflows

Royalty Pharma Acquires Royalty Interest in Nuvalent’s Neladalkib and Zidesamtinib for Up to $315 Million

Tonix Pharmaceuticals Announces Licensing TNX-4900, a Selective Sigma-1 Receptor Antagonist for Chronic Neuropathic Pain from Rutgers University

Insulet - Insulet to Participate in 44th Annual J.P. Morgan Healthcare Conference

Glaukos Announces Participation in J.P. Morgan Healthcare Conference

Energous’ PowerBridge Pro Gains EU Approval, Unlocking Wireless Power in Europe

Pfizer Inc. - Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance